SCHEMBL8567234

SCHEMBL8567234

COc1cccc(CN2CCC(N3C(=O)Nc4ccccc4C3c3cccc(O)c3)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.50
CHRM3 P20309 2/20 0.50
OPRM1 P35372 1/20 0.49
DRD2 P14416 2/20 0.47
DRD4 P21917 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
CCR8 P51685 1/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
PDE5A O76074 1/20 0.42
PDE11A Q9HCR9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565700 0.92 CHRM3 (0.56) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6166416 0.91 CHRM3 (0.52) CHRM2CHRM3OPRM1DRD2DRD4
Hydrochloric Acid SCHEMBL6168628 0.90 CHRM3 (0.52) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL8570359 0.90 CHRM3 (0.51) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6169679 0.90 CHRM3 (0.48) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL8571871 0.87 CHRM3 (0.54) CHRM2CHRM3OPRM1DRD2SIGMAR1
SCHEMBL8569665 0.83 CCR8 (0.46) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6165720 0.83 CHRM3 (0.47) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL8571599 0.83 CHRM3 (0.46) CHRM2CHRM3OPRM1DRD2DRD4
SCHEMBL6166931 0.83 CHRM3 (0.43) CHRM2CHRM3OPRM1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed